EMBRYOCHEK46 is a preimplantation genetic testing for aneuploidies (PGT-A) that comprehensively screens all the 46 chromosomes of a day-5/6 embryo from IVF by high-resolution Next Generation Sequencing (hr-NGS) for abnormalities. At RGCS, we are committed to offering the most advanced high-resolution PGT-A technology to enable the most informed embryo selection for a successful fertility treatment.

Our Promise to Clients;
  • Rapid Turnaround Time of 10 days or less
  • Detailed and Actionable Reporting that helps embryo selection with your patients
  • Uncompromised Quality (Quality is our Culture)


The PGT-A workflow uses high-throughput whole-genome amplification and low-pass whole genome sequencing method, using the Ion Torrent Semiconductor Sequencing Technology (Life Technologies). This most advanced high-resolution PGT-A method identifies numerical abnormalities (also know as copy number variations) in all the 46 chromosomes, identifies regions of the genome that are duplicated or deleted typically from ~10 Mb up to a whole chromosome starting from a single cell.

Our hr-PGT-A detects;
  • Ploidy status of all 23 chromosome pairs
  • Segmental deletions
  • Segmental gains
  • Mosaicism.